AlphaValue/Baader Europe on Monday downgraded Swiss pharmaceutical group Roche (RO.SW) to reduce from add and increased its price target to 389 francs from 387 francs.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)